🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Sharing a commentary by our group, led by Parsa Erfani. Part of JCO Global Oncology and Union for International #CancerControl #WCC2022 series on Driving Innovation to Advance Cancer Equity We outline lessons from HIV innovation & important principles for leveraging cancer molecular dx in LMICs ascopubs.org/go/special/ser…

Milbank Memorial Fund & The Milbank Quarterly Sachin H. Jain, MD, MBA Forbes Health Care Payment Learning and Action Network (4/7) In our new piece, we argue this principle should be a North Star for Medicare reforms: defining success as “improved health with “financial non-inferiority” as opposed to the current standard of financial savings with ”clinical non-inferiority.”

#Viewpoint proposes restructuring World Health Organization (WHO)'s Model List of Essential Medicines to formally remove consideration of cost and cost-effectiveness from the expert committee reviews of clinical effectiveness, safety, and public health value. ja.ma/3syL1AE

Excellent piece by Adam Beckman MD - grappling with these "never events" of social harm in hospitals come up on rounds nearly every day.

We hear it often: "Kaiser spends $50M on housing," "United HC donates $3M to food security..." so we asked, how much are private insurers REALLY spending on #SDOH? Our work in JGIM Journal of General Internal Medicine attempts to answer this Q -- you may or may not be surprised. link.springer.com/article/10.100… 1/x

I have a new paper out with Shawn Johnson @maituranci Brigham and Women's Medicine Residents’ Sonja Solomon & Nora Osman. We found 1) an association between representation among practicing physicians and the following year’s MD students’ residency application rates by race. 1/ jamanetwork.com/journals/jaman…

Parsa Erfani et al. compare costs of #biomarker analysis methods for #breastcancer diagnosis in #Rwanda 👉bit.ly/3HofREm #cancerequity #beatNCD #globalonc

In our recent ASTRO IJROBP - The Red Journal paper, we quantify geographic access to radiotherapy in sub-Saharan Africa. While # of machines/centers is important, their locations relative to the population is just as important. sciencedirect.com/science/articl… IAEA PACT Dana-Farber Division of Population Sciences WHO African Region

The United States invested $337 million pre-pandemic and $29.2 billion during the pandemic for mRNA Covid vaccines bmj.com/content/380/bm… The BMJ Hussain Lalani, MD, MPH, MSc Aaron Kesselheim and colleagues

Hospitals across the U.S. are building programs to address health-related social needs & #SDOH What can we learn from hospitals in Massachusetts that are often on the frontier of care delivery innovation? We explore in NEJM Catalyst & find that.. catalyst.nejm.org/doi/full/10.10… 1/x

This is the first ever #voluntarylicense #VL for a an NCD or cancer drug. ATOM Coalition @UICC and our partners are happy to see the process moving forward, hoping to establish a new mechanism to bring innovative medicines to every person who needs it everywhere in the world

Health care is making Americans poorer. In NEJM, we describe the current burden of medical debt, the history of our health financing system, and solutions to endemic medical debt in the US. nej.md/3P1X2tc 1/10

Check out my recent TED-style talk Harvard T.H. Chan School of Public Health "Taking Pharmacoequity Global: the Right to Access Cancer Medicines" youtu.be/DFFk_zsgS2o?si… (my talk starts at the 20 minute mark)

A strategy is spreading in Medicare Advantage — insurers are increasingly advertising specific plans to specific people based on identity. We explore these emerging Medicare Advantage “Affinity Plans” in a new viewpoint. jamanetwork.com/journals/jama/… /1

Happening today! Ethical Decision-Making in Global Health with keynote lecture from the Amazing Dr. Fadelu Dayo Fadelu This is going to be educative! Registration is free! massmed.zoom.us/meeting/regist…